91271-84-0

Usage

Uses

Used in Pharmaceutical Research:
4-(Morpholinomethyl)benzylamine is used as a key intermediate in the synthesis of various drugs. Its unique structure allows for the development of pharmaceuticals with novel therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Production:
In the agrochemical industry, 4-(Morpholinomethyl)benzylamine serves as an essential intermediate for the creation of new agrochemicals. Its incorporation into these products can lead to the discovery of more effective and environmentally friendly solutions for agricultural challenges.
Used in Organic Synthesis:
4-(Morpholinomethyl)benzylamine is utilized as a versatile building block in organic synthesis. Its ability to form a wide range of chemical structures makes it a valuable component in the synthesis of complex organic molecules for various applications, including but not limited to pharmaceuticals, agrochemicals, and other specialty chemicals.

InChI:InChI=1/C12H18N2O/c13-9-11-1-3-12(4-2-11)10-14-5-7-15-8-6-14/h1-4H,5-10,13H2

Upstream product

• 17201-43-3 4-cyanobenzyl bromide 
• 37812-51-4 4-(morpholin-4-ylmethyl)benzonitrile 
• 874888-96-7 (4-morpholin-4-ylmethyl-benzyl)-carbamic acid tert-butyl ester 

Downstream Products

• 1335105-06-0 C₃₅H₃₈N₄O₆ 

Relevant academic research and scientific papers

Cyano-pyrrolo-heteroaryl derivative, preparation method thereof and application of derivative to medicine

The invention relates to a cyano-pyrrolo-heteroaryl derivative, a preparation method thereof and an application of the derivative to medicine, and particularly relates to a novel cyano-pyrrolo-heteroaryl derivative as shown in a general formula (I), a pre

Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition

Protein kinases are promising therapeutic targets for cancer therapy. Here, we applied multiple approaches to optimize the potency and selectivity of our reported alloxazine scaffold. Flexible moieties at position 2 of the hetero-tricyclic system were inc

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.

6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS

The present invention provides 6-substituted 2,3,4,5-tetrahydro-lH- benzo[d]azepines of Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety, where, R6 is -NR10R11, where R10 is substituted phenylalkyl or substituted pyridylalkyl and other substituents are as defined in the specification.

QUATERNARY SALT CCR2 ANTAGONISTS

Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.

Quaternary salt CCR2 antagonists

Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.

Thiazolopyridine kinase inhibitors

The present invention is directed to novel thiazolopyridines, pharmaceutical compositions thereof, and the use thereof as inhibitors of ATP-protein kinase interactions. The thiazolopyridine compounds have the following Formula (I):

Imidazole derivatives

The present invention relates to the imidazole derivative of the following formula (I) wherein R1 is hydrogen, optionally substituted alkyl and the like, R2 is hydrogen, optionally substituted alkyl and the like, R3is optionally substituted heteroaryl, R4 is optionally substituted cycloalkyl, optionally substituted phenyl and the like, provided that when R1 is hydrogen, and R2 and R4 are the same or different and each is phenyl or phenyl substituted by halogen atom, lower alkyl or lower alkoxy, R3 is benzothiazolyl or thiazolyl substituted by phenyl, the imidazole derivative of the following formula (XII) wherein R6 is optionally substituted phenyl or optionally substituted heteroaryl and R7 is substituted phenyl, and pharmaceutically acceptable salts thereof. The compounds of the formulas (I) and (XII) and pharmaceutically acceptable salts thereof of the present invention inhibit IL-4 and IL-5 production by Th2 cells and are effective for the prophylaxis and treatment of allergic diseases such as atopic dermatitis, bronchial asthma, allergic rhinitis and the like.